CV

Professional Experience

Stir (2020 – 2021; remote): Product and Strategy Lead

Stir is a venture-backed company focused on building technology to empower the rapidly expanding creator economy.

Maximus (2020 – 2021; remote): VP Product and Strategy

Maximus is a consumer health company that provides men with content, community, and clinical support to optimize them in mind and body. Maximus raised $5M from top Silicon Valley VCs such as Founders Fund and 8VC as well as leading angel investors/operators

  • Provided product and operational leadership culminating in release of MVP version of company’s first subscription product offering in Q2 2021
  • Oversaw team of engineers & designers supporting all software product and internal systems development within company
  • Developed user-friendly patient experience and compliant legal & software infrastructure needed for multi-state telemedicince operations in coordination with regulatory, finance, pharmacy partners, clinical labs partners, electronic medical record, clinicians, and other third parties
  • Built “operator manual” for launch operations that can be handed over to non-technical staff
  • Guided roadmap for further state and product launches, user experience enhancements, and infrastructure / operational improvements
  • Team member #1 with oversight over company’s fundraising close, as well as set up of initial legal, finance, and HR systems
  • Continuing to serve as an advisor

1955 Capital (2016 – ; Bay Area): Venture Partner

1955 Capital is a U.S.-based venture capital firm that invests in technologies from the developed world that can help solve the developing world’s greatest challenges in areas like energy, the environment, food safety, health, education, and manufacturing. 

  • Employee #1 with far-ranging responsibilities including sourcing, due diligence, fundraising, deal execution, team construction, and process creation
  • Generalist within the firm with emphasis across hard technologies (cleantech and healthcare)
  • Worked directly with portfolio company management teams including Gridtential, Nature’s Fynd, and other still-unannounced investments in energy, diagnostics, and advanced materials
  • Created firm’s first special purpose vehicles for investments leveraging alternative capital formation as strategy

HealthPals (2020; Bay Area): Product Consultant

HealthPals works with leading Life Science companies and value-based care organizations to build products backed by Real World Evidence / Real World Data, including data-driven dashboards, clinical trial design optimization, and external control arms.

  • Provided product management, design & engineering leadership, and strategic guidance for several of company’s product efforts
  • Overhauled prior dashboard product to improve usability and support insight needs for commercial / medical affairs customers within life sciences organizations
  • Developed care gap closure use case for payer / value-based provider customers and built framework for opportunity sizing to facilitate pitches
  • Built initial concept prototypes on clinical trial optimization / external control arm product

Yik Yak (2014 – 2015; Atlanta): VP, Product & Business Development

Yik Yak was a venture-backed startup building hyperlocal communities for mobile devices which has raised over $70M in venture funding since its inception.

  • Drove Series B fundraising process leading to a $60M+ financing
  • Built and managed team of 6 PMs, designers, and UX researchers supporting all product and systems development within company
  • Guided roadmap and implementation of over 1 year of releases including multiple key features (phone number verification, reply icons, notification center, My Herd, sharing, web)
  • Handled all preliminary partnership conversations and executed on partnerships with University of Florida, MTV, Comedy Central, and Bleacher Report

DCM (2010 – 2014;  Bay Area): VP, Investments

DCM is a leading early stage venture capital fund based in the Silicon Valley, Beijing, and Tokyo, managing over $3B in assets.

  • Generalist within firm with emphasis on opportunities in hard technologies (cleantech, semiconductors), connected platforms (MVNO, smart TV, OTT streaming), and new models for healthcare
  • Drove due diligence processes on and worked directly with management at portfolio companies on product strategy, fundraising, financial planning, business development and hiring including SoFi, Whistle, 1Mainstream, Analogix, Matterport, PlayStudios, Cognitive Networks, and Enovix
  • Built software tool to programmatically parse data from AppAnnie (mobile app store rankings data vendor)

Bain & Company (2007 – 2010;  Bay Area): Senior Associate Consultant

Bain & Company is a leading management consulting firm.

  • Performed competitive benchmarking to compare a client’s manufacturing operations with industry best-in-class
  • Analyzed technology industry profitability to identify attractive growth vectors for large tech client and highlight key differences between profit/power concentration in different verticals
  • Conducted financial and strategic diligence on wide range of potential acquisition targets (ranging in value from ~$100M to over $50B) to map out strategic acquisition options and gameboarding scenarios for a Fortune 500 technology client
  • Facilitated concept development and pilot phase of client initiative to provide operational support services for supply chain
  • Provided strategic and financial analysis to aid multiple clients in determining appropriate response to potentially disruptive trends; topics covered include cloud computing, mobile commerce, next-generation semiconductor manufacturing, cross-border eCommerce, social networking, etc.
  • Devised presentation for CEO-level conversation on a process to pro-actively acquire/partner with assets which can aid client in dealing with disruptive innovations
  • Overhauled Bain toolkit for codification in book by Bain partners Mark Gottfredson and Steve Schaubert, The Breakthrough Imperative

Roche Pharmaceuticals (2005; Palo Alto, CA): Research Intern, Drug Metabolism & Pharmacokinetics

Roche Pharmaceuticals is a leading pharmaceutical company

  • Validated use of Isothermal Titration Calorimeter in enzyme kinetics studies
  • Assessed factors limiting application of approach to study of Cytochrome P450 enzyme system
  • Presented findings at department seminar

Abgenix Corporation (2003; Fremont, CA): Intern, Process Sciences

Abgenix was a biotechnology company focused on humanized antibody therapeutics which was acquired by Amgen in 2006

  • Performed optimization studies for ELISA protocols used by Abgenix’s Process Sciences division
  • Presented findings at department seminar

Academic Research

Stanford Ophthalmic Informatics and Artificial Intelligence Group (2019 – ; Stanford, CA): Stanford University Byers Eye Institute

Work with Professor Sophia Ying Wang applying AI/NLP methods to understanding and making predictions based on electronic medical record data. Output includes:

Maniatis Group (2004 – 2007; Cambridge, MA): Harvard University Department of Molecular and Cellular Biology

Completed senior thesis “Transcriptional Regulation of Members of the Tripartite Motif Family” (linkreport PDF) in lab of Professor Tom Maniatis.

Brenner Group (2006 – 2007; Cambridge, MA): Harvard University Division of Engineering and Applied Sciences

Worked with Professor Michael P. Brenner on applying separation of timescales and dominant balances towards simplifying complex biological math models, specifically with regards to what sets the Ran gradient in nuclear transport (linkreport PDF).

Brown Group (Summer 2004; Stanford, CA): Stanford Medical School Center for Clinical Science Research

Worked in the lab of Professor Janice (Wes) M. Y. Brown researching stem cell reconstitution of murine immune systems in conjunction with antifungal agents and combinations of lymphoid and myeloid progenitor cells. Research summarized in: Arber C, et al. Journal of Infectious Diseases [2005]

Education

Harvard University (2003 – 2007; Cambridge, MA): A. B. Magna Cum Laude with Highest Honors in Biochemical Sciences, Secondary Field in Mathematical Sciences

  • Honors: Phi Beta Kappa, Dean’s Research Award (2006), Harvard College Research Program Award (2006), Harvard College Scholar (2005-2006), Tylenol Scholar (2005-2006)
  • Thesis: Transcriptional Regulation of Members of the Tripartite Motif Family in Response to Viral Infection (link)
  • Selected Activities
    • Harvard College Asian Business Forum: Operations Director (2005-2006)
    • Next Generation MD: Associate Editor (2005-2007), writer
    • Harvard International Review: Media Department Head (2004-2005), Visuals Editor(2003-2004)

Skills/Other